Skip to main content
Back to Trials
NCT07856641Recruiting

Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients

The University of Texas Health Science Center, Houston

Start Date

8/26/2026

Completion Date

3/26/2028

Summary

The purpose of this study is to determine whether a circadian rhythm exists in anti-FXa levels and AT3 activity in hospitalized trauma patients receiving low-molecular-weight heparin (LMWH) chemoprophylaxis

Eligibility Criteria

Age Range: 18 years to 80 years

Inclusion Criteria: * Inpatient admission for acute traumatic injury ≥72 hours * Prescribed LMWH subcutaneous for VTE chemoprophylaxis Exclusion Criteria: * Pregnancy * Brain hemorrhage or non-survivable injury * Chronic Kidney disease ≥ 3b estimated Glomerular Filtration Rate (eGFR) less than 30 interferes with coagulation * Chronic liver failure •-Acute stimulant use of cocaine and methamphetamine * Active VTE or ongoing anticoagulation at admission * History of coagulopathy or inherited bleeding disorders * Chronic alcohol as defined as a documented diagnosis of alcohol use disorder or alcohol consumption exceeding established risk thresholds (men \>14 drinks/week; women \>7 drinks/week) within the prior 3-6 months * Unmanaged psychiatric conditions as defined as diagnosed psychiatric disorder with evidence of inadequate or no active treatment or documented poor symptom control * Neurologic injury involving hypothalamic or circadian regulatory centers

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity

Locations

HCA Houston Northwest Medical Center

Houston, Texas 77090

United States